Department of Dermatology

Tolerability of BRAF/MEK inhibitor combinations: Adverse event evaluation and management (2019) Heinzerling L, Eigentler TK, Fluck M, Hassel JC, Heller-Schenck D, Leipe J, Pauschinger M, et al. Journal article, Review article Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology (2019) Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, et al. Journal article, Letter Psychiatric disorders are common comorbidities in patients with chronic spontaneous or inducible urticaria in Germany (2019) Weller K, Maurer M, Bauer A, Wedi B, Wagner N, Schliemann S, Baeumer D, et al. Conference contribution Age as a Key Factor in the Pattern, Extent and timing Process of Distant Metastasis in Patients with malignant Melanoma. A Study by the German Central Register of Malignant Melanoma (2019) Gassenmaier M, Leiter U, Eigentler T, Roecken M, Keim U, Gesierich A, Moritz R, et al. Conference contribution First real-world insights on benefit of apremilast treatment in patients with moderate to severe psoriasis after switching from fumaric acid esters from the APART Study - an interim analysis (2019) Mrowietz U, Ertner K, Sticherling M, Grosse V, Popp G, Roemmler-Zehrer J, Lampl M, et al. Conference contribution Therapy Options for Patients with Advanced Basal Cell Carcinoma (2019) Kirchberger MC Conference contribution Trauma as a Trigger Factor for the First clinical Manifestation of cutaneous Leishmaniasis (2019) Hiernickel J, Bogdan C, Erfurt-Berge C Conference contribution The Art of Making Moulages - a hidden Art? (2019) Sticherling M, Groenhardt K, Saake M Conference contribution Pruritus in Psoriasis - Correlation to the Severity of the clinical appearance of the Skin? (2019) Achterberg FL, Kremer A, Sticherling M Conference contribution Multiple dermal Abscesses by Trichophyton rubrum in an immunosuppressed Patients (2019) Toussaint F, Sticherling M Conference contribution